Best response during induction and maintenance therapy according to cytogenetic abnormalities
| . | Standard-risk (n = 188) . | High-risk (n = 44) . | P . |
|---|---|---|---|
| After induction therapy with VMP/VTP | |||
| IF− CR | 27% | 21% | NS |
| IF+ CR | 10% | 11% | NS |
| PR | 45% | 47% | NS |
| After maintenance therapy with VT/VP | |||
| IF− CR | 45% | 40% | NS |
| IF+ CR | 13% | 11% | NS |
| PR | 38% | 50% | NS |
| . | Standard-risk (n = 188) . | High-risk (n = 44) . | P . |
|---|---|---|---|
| After induction therapy with VMP/VTP | |||
| IF− CR | 27% | 21% | NS |
| IF+ CR | 10% | 11% | NS |
| PR | 45% | 47% | NS |
| After maintenance therapy with VT/VP | |||
| IF− CR | 45% | 40% | NS |
| IF+ CR | 13% | 11% | NS |
| PR | 38% | 50% | NS |
PR indicates partial response.